Progesterone Microspheres Pharmacokinetic - Pharmacodynamic (PK-PD) Study

Update Il y a 4 ans
Reference: NCT01176175

Woman Man

  • | Country :
  • Mexico
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Phase: I pharmacokinetic - pharmacodynamic (PK-PD) study. Main objective: To establish the minimum effective dose of progesterone microspheres suspension, which administered by weekly intramuscular injection, will be able to induce transformation from a proliferative endometrium to a secretory endometrium. Study design: Randomized, controlled, open-label, parallel, dose-response clinical trial. Sites: 1 Subjects: 48 postmenopausal women.


Inclusion criteria

  • Infertility

Links